All articles by Himaja Ganta

Himaja Ganta

US and UK provide defensive security assistance to Ukraine

The new funding from the US was approved last month.

Russia conducts military drills amid tensions with Ukraine

Approximately 3,000 personnel are participating in the exercises conducted in the regions of Voronezh, Belgorod, Bryansk, and Smolensk.

Somru and Veeda Clinical form bioanalytical laboratory in Ahmedabad, India

Contract research organisation (CRO) Veeda Clinical Research and Canadian biotechnology firm Somru BioScience have established a bioanalytical laboratory in Ahmedabad, India.

Altasciences completes acquisition of US-based CRO WCCT Global

Mid-size CRO/CDMO Altasciences has acquired early-stage clinical research organisation (CRO) WCCT Global.

Bionic Vision advances clinical programme with Australian government grant

Melbourne-based Australian medical technology start-up Bionic Vision Technologies (BVT) has announced that it is advancing next phase of development for its clinical programme after receiving a grant from the Australian Government.

Oncology consultancy Physiomics signs new agreement with ValiRx

UK-based oncology consultancy company Physiomics has signed a new agreement with clinical stage drug development company ValiRx.

Javara and Wake Forest Baptist to provide clinical research services

Integrated research organisation (IRO) Javara and academic health system Wake Forest Baptist Health have signed an integrated research agreement, extending their partnership to provide clinical research services.

Moleculin receives grant for Phase IB/II sarcoma trial of Annamycin

Moleculin Biotech has announced that Polish state agency Agencja Badań Medycznych (The Medical Research Agency) awarded a $1.5m grant to the Maria Sklodowska-Curie National Research Institute for a Phase IB/II clinical trial of Annamycin.

Medidata expands partnership with Horizon Therapeutics for trials

American technology firm Medidata, a subsidiary of Dassault Systèmes, has expanded its partnership with biopharmaceutical company Horizon Therapeutics to improve efficiencies and outcomes in clinical trials.

Innovo and Agilon partner to boost physician trial participation

Innovo Research and Agilon health have announced a strategic collaboration to increase participation of independent physicians in clinical trials across the US.